Literature DB >> 22577647

Use of a new collagen matrix (mucograft) for the treatment of multiple gingival recessions: case reports.

Roberto Rotundo1, Giovanpaolo Pini-Prato.   

Abstract

The aim of this case report study was to demonstrate the use of a new collagen matrix as an alternative to the connective tissue graft for the treatment of multiple gingival recessions. Three women showing 11 maxillary gingival recessions were treated by means of the envelope flap technique associated with a novel collagen matrix as a substitute for the connective tissue graft. At 1 year, complete root coverage was achieved in 9 treated sites, with a mean keratinized tissue width of 3.1 mm, complete resolution of dental hypersensitivity, and a high level of esthetic satisfaction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22577647

Source DB:  PubMed          Journal:  Int J Periodontics Restorative Dent        ISSN: 0198-7569            Impact factor:   1.840


  4 in total

1.  Blood flow changes using a 3D xenogeneic collagen matrix or a subepithelial connective tissue graft for root coverage procedures: a pilot study.

Authors:  Nikolaos Tatarakis; Nikolaos Gkranias; Ulpee Darbar; Nikolaos Donos
Journal:  Clin Oral Investig       Date:  2017-10-27       Impact factor: 3.573

2.  The efficacy of a porcine collagen matrix in keratinized tissue augmentation: a 5-year follow-up study.

Authors:  C Maiorana; L Pivetti; F Signorino; G B Grossi; A S Herford; M Beretta
Journal:  Int J Implant Dent       Date:  2018-01-10

3.  Comparison of two soft tissue substitutes for the treatment of gingival recession defects: an animal histological study.

Authors:  Fernando Suárez-López Del Amo; Juan C Rodriguez; Farah Asa'ad; Hom-Lay Wang
Journal:  J Appl Oral Sci       Date:  2019-10-07       Impact factor: 2.698

4.  Smile esthetic evaluation of mucogingival reconstructive surgery.

Authors:  Roberto Rotundo; Luigi Genzano; Michele Nieri; Ugo Covani; David Peñarrocha-Oltra; Miguel Peñarrocha-Diago
Journal:  Odontology       Date:  2020-08-09       Impact factor: 2.634

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.